We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
–
AUM
$4.05B
AUM Growth
+$38.8M
Cap. Flow
-$116M
Cap. Flow %
-2.87%
Top 10 Hldgs %
18.39%
Holding
733
New
60
Increased
226
Reduced
298
Closed
60

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$27.2M
2
AMZN icon
Amazon
AMZN
+$19.4M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$17.8M
4
EAT icon
Brinker International
EAT
+$15.8M
5
APD icon
Air Products & Chemicals
APD
+$15.1M

Top Sells

Rank Stock Value
1
CLX icon
Clorox
CLX
+$24.7M
2
DIS icon
Walt Disney
DIS
+$19.9M
3
TGT icon
Target
TGT
+$19M
4
DRI icon
Darden Restaurants
DRI
+$18.6M
5
CI icon
Cigna
CI
+$17.6M

Sector Composition

Rank Sector Weight
1 Healthcare 17.77%
2 Technology 14.35%
3 Financials 11.2%
4 Industrials 10.03%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EHC icon
51
Encompass Health
EHC
$11B
$19.6M 0.48%
607,550
+420,498
+225% +$13.6M
HD icon
52
Home Depot
HD
$332B
$19.3M 0.48%
149,959
-97,750
-39% -$13M
PRU icon
53
Prudential Financial
PRU
$42.6B
$19.3M 0.48%
236,344
-5,103
-2% -$391K
T icon
54
AT&T
T
$159B
$19.2M 0.47%
626,567
-8,891
-1% -$281K
MOH icon
55
Molina Healthcare
MOH
$10.2B
$19.2M 0.47%
329,143
+19,240
+6% +$1.06M
CLGX
56
DELISTED
Corelogic, Inc.
CLGX
$19.2M 0.47%
488,641
-1,212
-0.2% -$48.3K
INTC icon
57
Intel
INTC
$460B
$19M 0.47%
503,848
-8,549
-2% -$303K
ANDV
58
DELISTED
Andeavor
ANDV
$19M 0.47%
238,914
-33,702
-12% -$2.6M
WFC icon
59
Wells Fargo
WFC
$258B
$19M 0.47%
428,990
-198,315
-32% -$9.49M
ICLR icon
60
Icon
ICLR
$12.8B
$18.9M 0.47%
244,734
+3,427
+1% +$258K
ETR icon
61
Entergy
ETR
$50.4B
$18.8M 0.46%
490,412
+138,148
+39% +$5.5M
MRK icon
62
Merck
MRK
$321B
$18.8M 0.46%
315,116
-77,045
-20% -$4.51M
HRL icon
63
Hormel Foods
HRL
$14B
$18.7M 0.46%
494,060
-155
-0% -$5.76K
HELE icon
64
Helen of Troy
HELE
$649M
$18.7M 0.46%
217,285
-7,705
-3% -$722K
VLO icon
65
Valero Energy
VLO
$92.6B
$18.6M 0.46%
350,844
+8,907
+3% +$475K
SLB icon
66
SLB Ltd
SLB
$72.6B
$18.5M 0.46%
234,985
+50,756
+28% +$4.03M
OTEX icon
67
Open Text
OTEX
$6.15B
$18.4M 0.45%
565,922
+10,860
+2% +$339K
SNI
68
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$18.3M 0.45%
288,329
+103,894
+56% +$6.65M
LLY icon
69
Eli Lilly
LLY
$1.03T
$18.3M 0.45%
227,893
-5,323
-2% -$426K
WP
70
DELISTED
Worldpay, Inc.
WP
$18.2M 0.45%
324,220
-10,988
-3% -$610K
CTXS
71
DELISTED
Citrix Systems Inc
CTXS
$18.1M 0.45%
267,360
-4
-0% -$272
KR icon
72
Kroger
KR
$35.4B
$17.8M 0.44%
599,563
-214,489
-26% -$7.13M
IWF icon
73
iShares Russell 1000 Growth ETF
IWF
$120B
$17.7M 0.44%
678,620
+11,200
+2% +$291K
EA icon
74
Electronic Arts
EA
$52.9B
$17.5M 0.43%
204,758
-126,975
-38% -$10.2M
INGR icon
75
Ingredion
INGR
$6.33B
$17.3M 0.43%
129,658
-57,859
-31% -$7.73M
1 2
3
4 5

Similar funds

GVI
Green Valley Investors Wilmington, Delaware $1.76B AUM 5.64% 1-Year Est. Return
GMI
Greystone Managed Investments Regina, Saskatchewan, Canada $1.65B AUM 7.9% 1-Year Est. Return
CA
Cortland Advisers Wilmington, Delaware $2.18B AUM 8.82% 1-Year Est. Return
AWM
Ashmore Wealth Management Wilmington, Delaware $1.58B AUM 9.28% 1-Year Est. Return
CC
CQS Cayman Camana Bay, Grand Cayman, Cayman Islands $2.26B AUM 1.31% 1-Year Est. Return
STMM
South Texas Money Management San Antonio, Texas $2.37B AUM 5.24% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
TAM
Tiverton Asset Management Wilimington, Delaware $2.88B AUM 5.6% 1-Year Est. Return

Boston Advisors's Q3 2016 Portfolio in Review

As of Q3 2016, Boston Advisors held 733 positions worth $4.05B, up 0.97% from $4.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Advisors's Q3 2016 filing shows 60 new, 226 increased, 298 reduced and 60 closed positions. Its largest new stake was Vertex Pharmaceuticals: 188,245 shares worth $16.4M. The largest sale was Clorox, an estimated $24.7M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

  • Boston Advisors's largest Q3 2016 buy was Vertex Pharmaceuticals: 188,245 shares worth $16.4M.
  • Boston Advisors added most to AbbVie in Q3 2016, an estimated $27.2M increase.
  • Boston Advisors's biggest Q3 2016 reduction was Clorox, cutting an estimated $24.7M.
  • Boston Advisors fully exited Cadence Design Systems in Q3 2016, selling an estimated $14.4M.
  • Boston Advisors's ten largest holdings make up 18% of its $4.05B portfolio in Q3 2016.
  • Boston Advisors opened 60 new positions and closed 60 in Q3 2016.
  • Boston Advisors's portfolio value rose 0.97% quarter-over-quarter to $4.05B.

Based on Boston Advisors's 13F filing for Q3 2016, filed 25 Oct 2016.